Bill > A09507

This bill modifies existing insurance laws concerning high-deductible health plans (HDHPs) and health savings accounts (HSAs) to ensure that certain cost-sharing requirements, particularly for prescription drugs, do not cause individuals to become ineligible for HSAs under federal law (specifically, section 223 of the Internal Revenue Code). It clarifies that for HDHPs offered with HSAs, coverage for prescription drugs, including the application of discounts and financial assistance, will count towards the plan's annual deductible rather than being immediately applied to copayments or coinsurance, unless the drug is considered preventive care. The bill also adjusts the effective date of related legislation from immediately to January 1, 2027, applying to policies and contracts issued, renewed, modified, altered, or amended on or after that date, while other sections of this bill take effect concurrently with the 2025 law they amend.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A9507